Takeda moves for judgment against retailers' US antitrust claims over Amitiza
MLex Summary: Takeda Pharmaceuticals told a US federal judge that retailers should not be allowed to bring antitrust claims based on purported assignments from drug wholesalers that plaintiffs each admit are...To view the full article, register now.
Already a subscriber? Click here to view full article